期刊文献+

声触诊组织定量分析技术无创性评价慢性肾病的应用价值 被引量:6

Noninvasive evaluation of chronic kidney disease by virtual touch tissue quantification imaging
下载PDF
导出
摘要 目的:应用声触诊组织定量技术(Virtual touch tissue quantification,VTQ)探讨慢性肾病(CKD)患者肾实质弹性变化。方法:选取107例不同临床分期CKD患者和20例健康志愿者,应用VTQ技术测量双肾实质剪切波传播速度(Shear wave velocity,SWV)并进行比较,分析CKD患者肾实质组织弹性变化与临床分期、血肌酐水平变化的相关性。结果:CKD 2期、3期、4期、5期患者肾实质剪切波速度(SWV)明显低于1期患者及正常对照组,差异有统计学意义(P<0.001);慢性肾病4期、5期患者肾实质SWV与1期、2期、3期患者比较差异有统计学意义(P<0.05);CKD 4期与5期之间,2期与3期之间,1期与正常对照组之间比较,肾实质SWV差异无统计学意义(P值分别为0.996,0.339,0.139);CKD患者肾实质SWV值与临床分期、血肌酐水平呈负相关关系(r=-0.596,-0.458;P均<0.001)。结论:VTQ能够量化反映肾实质组织弹性硬度变化,有望成为无创性定量评估CKD肾实质功能损害的新指标。 Objective: To evaluate virtual touch tissue quantification (VTQ) imaging in chronic kidney disease. Methods: VTQ, given shear wave velocity(SWV), of the renal parenchyma was measured in 107 patients with chronic kidney disease and 20 healthy volunteers. The mean SWV measurements were compared in different stage groups and control volunteers. Correla- tions between SWV measurements and clinical stage or serum creatinine were investigated. Results: The mean SWV in stage 2, stage 3, stage 4 and stage 5 patients with chronic kidney disease were significantly lower than that in stage 1 and volun- teer groups (P〈0.001); There were significant differences between stage 4, stage 5 vs stage 1, stage 2 and stage 3 patient groups (P〈0.05); SWV did not differ significantly in stage 4 vs stage 5, stage 2 vs stage 3, and stage 1 vs control volunteers (P=0.996, 0.339, 0.139, respectively). The mean SWV of renal parenchyma were negatively correlated with clinical stage(Spear- man r=-0.596, P〈0.001) and serum creatinine(Pearson r=-0.458, P〈0.001). Conclusions: VTQ imaging is a promising noninva- sire technique for evaluation renal elasticity in chronic kidney disease patients.
出处 《中国临床医学影像杂志》 CAS 2013年第9期647-649,共3页 Journal of China Clinic Medical Imaging
基金 广西自然科学基金青年基金项目(2012GXNSFBA053083) 国家自然科学基金项目(81260223)
关键词 肾功能衰竭 慢性 超声检查 多普勒 彩色 Kidney failure, chronic Ultrasonography, Doppler, color
  • 相关文献

参考文献5

二级参考文献53

  • 1赵子卓,罗葆明.超声弹性成像基本原理及技术[J].中国医疗器械信息,2008,14(4):6-8. 被引量:74
  • 2Fraquelli M, Rigamonti C, Casazza G, Conte D, Donato MF, Ronchi G, Colombo M. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 2007; 56:968-973.
  • 3Castera L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, Darriet M, Couzigou P, De Ledinghen V. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128:343-350.
  • 4Chang J, Tan HH, Yew BS. Transient elastography (FibroScan) to assess hepatic fibrosis in Chinese with chronic hepatitis B. 17th Asian Pacific Association for the Study of Liver Conference. 2007.
  • 5Kim KM, Choi WB, Park SH, Yu E, Lee SG, Lim YS, Lee HC, Chung YH, Lee YS, Suh DJ. Diagnosis of hepatic steatosis and fibrosis by transient elastography in asymptomatic healthy individuals: a prospective study of living related potential liver donors. J Gastroentero12007; 42:382-388.
  • 6Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, de Ledinghen V, Marcellin P, Dhumeaux D, Trinchet JC, Beaugrand M. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005; 41:48-54.
  • 7Roulot D, Czernichow S, Le Clesiau H, Costes JL, Vergnaud AC, Beaugrand M. Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome. J Hepatol 2008; 48:606-613.
  • 8Rifai K, Bahr MJ, Mederacke I, Bantel H, Bayer D, Boozari B, Wedemeyer H, Manns MP, Gebel M. Acoustic Radiation Force Imaging (ARFI) as a new method of Ultrasonographic elastography allows accurate and flexible assessment of liver stiffness. Copenhagen: Poster presentation EASL, 2009.
  • 9Poynard T, Halfon P, Castera L, Charlotte F, Le Bail B, Munteanu M, Messous D, Ratziu V, Benhamou Y, Bourliere M, De Ledinghen V. Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation. Aliment Pharmacol Ther 2007; 25:733-739.
  • 10Poynard T, Halfon P, Castera L, Munteanu M, Imbert-Bismut F, Ratziu V, Benhamou Y, Bourliere M, de Ledinghen V. Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages. Clin Chem 2007; 53:1615-1622.

共引文献878

同被引文献58

引证文献6

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部